ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,628Medicare Part D Prescriptions Filled, Including Refills

Rank: 105 out of 1942

$482K Total Retail Price of All Prescriptions

Rank: 113 out of 1942

482 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 482 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 482 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 6,542 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
LISINOPRIL 513 401 1 2
HYDROCODONE-ACETAMINOPHEN 482 251 S3 2 12
OMEPRAZOLE 446 268 3 4
SIMVASTATIN 355 269 4 1
LEVOTHYROXINE SODIUM 265 197 5 3
METOPROLOL SUCCINATE 252 220 6 13
FUROSEMIDE 248 189 7 5
METFORMIN HCL 244 198 8 10
HYDROCHLOROTHIAZIDE 235 214 9 8
ATENOLOL 196 151 10 7
TRAMADOL HCL 184 66 11 19
GABAPENTIN 164 74 12 16
WARFARIN SODIUM 159 149 13 11
AMLODIPINE BESYLATE 131 121 14 6
PRAVASTATIN SODIUM 129 101 15 23
ATORVASTATIN CALCIUM 128 107 16 14
LANTUS SOLOSTAR 126 94 17 54
METOPROLOL TARTRATE 123 107 18 9
ZOLPIDEM TARTRATE 123 80 18 25
ALLOPURINOL 114 74 20 26
AZITHROMYCIN 114 73 20 43
PREDNISONE 111 78 22 27
GLIPIZIDE 100 63 23 63
IBUPROFEN 95 53 24 78
CITALOPRAM HBR 93 64 25 15
DICLOFENAC SODIUM 88 59 26 136
TAMSULOSIN HCL 82 76 27 29
TRAZODONE HCL 79 55 28 24
SERTRALINE HCL 69 62 29 20
ISOSORBIDE MONONITRATE ER 66 66 30 42
PANTOPRAZOLE SODIUM 64 36 31 48
CYCLOBENZAPRINE HCL 58 0 R 32 73
ACETAMINOPHEN-CODEINE 57 23 S3 33 90
FENTANYL 53 0 S2 34 47
TRIAMCINOLONE ACETONIDE 52 42 35 71
POTASSIUM CHLORIDE 52 29 35 17
JANTOVEN 50 24 37 33
VENLAFAXINE HCL 50 35 37 182
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 27, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.